BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 29225091)

  • 21. Relationship between DNA Methylation Profiles and Active Tuberculosis Development from Latent Infection: a Pilot Study in Nested Case-Control Design.
    Du Y; Gao X; Yan J; Zhang H; Cao X; Feng B; He Y; He Y; Guo T; Xin H; Gao L
    Microbiol Spectr; 2022 Jun; 10(3):e0058622. PubMed ID: 35446152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptional Profiling of Human Peripheral Blood Mononuclear Cells Identifies Diagnostic Biomarkers That Distinguish Active and Latent Tuberculosis.
    Wang S; He L; Wu J; Zhou Z; Gao Y; Chen J; Shao L; Zhang Y; Zhang W
    Front Immunol; 2019; 10():2948. PubMed ID: 31921195
    [No Abstract]   [Full Text] [Related]  

  • 23. Potential Role for Mycobacterium tuberculosis Specific IL-2 and IFN-γ Responses in Discriminating between Latent Infection and Active Disease after Long-Term Stimulation.
    Sun Q; Wei W; Sha W
    PLoS One; 2016; 11(12):e0166501. PubMed ID: 28033330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of methylated HBHA expressed from Mycobacterium smegmatis in an IFN-γ release assay to aid discrimination between latent infection and active tuberculosis in BCG-vaccinated populations.
    Wen HL; Li CL; Li G; Lu YH; Li HC; Li T; Zhao HM; Wu K; Lowrie DB; Lv JX; Lu SH; Fan XY
    Eur J Clin Microbiol Infect Dis; 2017 Aug; 36(8):1415-1423. PubMed ID: 28429162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of immune cell response to M. tuberculosis-specific antigens by quantitative polymerase chain reaction.
    Bibova I; Linhartova I; Stanek O; Rusnakova V; Kubista M; Suchanek M; Vasakova M; Sebo P
    Diagn Microbiol Infect Dis; 2012 Jan; 72(1):68-78. PubMed ID: 22085772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of heat shock proteins for discriminating between latent tuberculosis infection and active tuberculosis: A preliminary report.
    Shekhawat SD; Purohit HJ; Taori GM; Daginawala HF; Kashyap RS
    J Infect Public Health; 2016; 9(2):143-52. PubMed ID: 26300163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjunctive biomarkers for improving diagnosis of tuberculosis and monitoring therapeutic effects.
    Hur YG; Kang YA; Jang SH; Hong JY; Kim A; Lee SA; Kim Y; Cho SN
    J Infect; 2015 Apr; 70(4):346-55. PubMed ID: 25452040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multifunctional Analysis of CD4+ T-Cell Response as Immune-Based Model for Tuberculosis Detection.
    Lichtner M; Mascia C; Sauzullo I; Mengoni F; Vita S; Marocco R; Belvisi V; Russo G; Vullo V; Mastroianni CM
    J Immunol Res; 2015; 2015():217287. PubMed ID: 26339657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening of potential biomarkers for distinguishing between latent and active tuberculosis in children using bioinformatics analysis.
    Shao M; Wu F; Zhang J; Dong J; Zhang H; Liu X; Liang S; Wu J; Zhang L; Zhang C; Zhang W
    Medicine (Baltimore); 2021 Feb; 100(5):e23207. PubMed ID: 33592820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Association between Circulating microRNAs and the Risk of Active Disease Development from Latent Tuberculosis Infection: a Nested Case-Control Study.
    Xin H; Cao X; Du Y; Yan J; He R; Liu Z; Zhang H; He Y; Zhang B; Wang D; Guan L; Shen F; Feng B; Quan Z; He Y; Liu J; Jin Q; Pan S; Gao L
    Microbiol Spectr; 2022 Jun; 10(3):e0262521. PubMed ID: 35435753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative and qualitative profiles of circulating monocytes may help identifying tuberculosis infection and disease stages.
    La Manna MP; Orlando V; Dieli F; Di Carlo P; Cascio A; Cuzzi G; Palmieri F; Goletti D; Caccamo N
    PLoS One; 2017; 12(2):e0171358. PubMed ID: 28208160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of Response to HBHA in HIV-Infected Patients with Latent Tuberculosis Infection.
    Delogu G; Vanini V; Cuzzi G; Chiacchio T; De Maio F; Battah B; Pinnetti C; Sampaolesi A; Antinori A; Goletti D
    Scand J Immunol; 2016 Dec; 84(6):344-352. PubMed ID: 27636597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Highly Multiplexed Proteomic Analysis of Quantiferon Supernatants To Identify Biomarkers of Latent Tuberculosis Infection.
    De Groote MA; Higgins M; Hraha T; Wall K; Wilson ML; Sterling DG; Janjic N; Reves R; Ochsner UA; Belknap R
    J Clin Microbiol; 2017 Feb; 55(2):391-402. PubMed ID: 27852671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biomarkers of iron metabolism facilitate clinical diagnosis in
    Dai Y; Shan W; Yang Q; Guo J; Zhai R; Tang X; Tang L; Tan Y; Cai Y; Chen X
    Thorax; 2019 Dec; 74(12):1161-1167. PubMed ID: 31611342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of plasma biomarkers for discrimination between tuberculosis infection/disease and pulmonary non tuberculosis disease.
    La Manna MP; Orlando V; Li Donni P; Sireci G; Di Carlo P; Cascio A; Dieli F; Caccamo N
    PLoS One; 2018; 13(3):e0192664. PubMed ID: 29543810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complement Component C1q as Serum Biomarker to Detect Active Tuberculosis.
    Lubbers R; Sutherland JS; Goletti D; de Paus RA; van Moorsel CHM; Veltkamp M; Vestjens SMT; Bos WJW; Petrone L; Del Nonno F; Bajema IM; Dijkman K; Verreck FAW; Walzl G; Gelderman KA; Groeneveld GH; Geluk A; Ottenhoff THM; Joosten SA; Trouw LA
    Front Immunol; 2018; 9():2427. PubMed ID: 30405622
    [No Abstract]   [Full Text] [Related]  

  • 37. Diagnostic performance of plasma cytokine biosignature combination and MCP-1 as individual biomarkers for differentiating stages Mycobacterium tuberculosis infection.
    Luo J; Zhang M; Yan B; Li F; Guan S; Chang K; Jiang W; Xu H; Yuan T; Chen M; Deng S
    J Infect; 2019 Apr; 78(4):281-291. PubMed ID: 30528869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel T-cell assays for the discrimination of active and latent tuberculosis infection: the diagnostic value of PPE family.
    Pourakbari B; Mamishi S; Marjani M; Rasulinejad M; Mariotti S; Mahmoudi S
    Mol Diagn Ther; 2015 Oct; 19(5):309-16. PubMed ID: 26245995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mycobacteria-Specific Cytokine Responses Detect Tuberculosis Infection and Distinguish Latent from Active Tuberculosis.
    Tebruegge M; Dutta B; Donath S; Ritz N; Forbes B; Camacho-Badilla K; Clifford V; Zufferey C; Robins-Browne R; Hanekom W; Graham SM; Connell T; Curtis N
    Am J Respir Crit Care Med; 2015 Aug; 192(4):485-99. PubMed ID: 26030187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of microRNA expression profiling identifies miR-155 and miR-155* as potential diagnostic markers for active tuberculosis: a preliminary study.
    Wu J; Lu C; Diao N; Zhang S; Wang S; Wang F; Gao Y; Chen J; Shao L; Lu J; Zhang X; Weng X; Wang H; Zhang W; Huang Y
    Hum Immunol; 2012 Jan; 73(1):31-7. PubMed ID: 22037148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.